---
kind: "section"
citation: "40 C.F.R. § 35.4075"
title: "40"
number: "35.4075"
heading: "Are there things my group can't spend TAG money for?"
url: "https://uscodex.org/cfr/40/35.4075"
---

# §35.4075. Are there things my group can't spend TAG money for?


Your TAG funds cannot be used for the following activities:

- (a) Lawsuits or other legal actions;
- (b) **Attorney fees for services—**
  - (1) Connected to any kind of legal action; or
  - (2) That could, if such a relationship were allowable, be interpreted as resulting in an attorney/client relationship to which the attorney/client privilege would apply;
- (c) The time of your technical advisor to assist an attorney in preparing a legal action or preparing and serving as an expert witness at any legal proceeding;
- (d) **Political activity and lobbying that is unallowable under 2 CFR part 200 Subpart E—** Cost Principles, (this restriction includes activities such as attempting to influence the outcomes of any Federal, State or local election, referendum, initiative, or similar procedure through in-kind or cash contributions, endorsements, or publicity, or attempting to influence the introduction or passage of Federal or state legislation; this regulation is available at http://www.ecfr.gov.)
- (e) **Other activities that are unallowable under the cost principles stated in 2 CFR part 200 Subpart E—** Cost Principles (such as costs of amusement, diversion, social activities, fund raising and ceremonials);
- (f) Tuition or other training expenses for your group's members or your technical advisor except as [§ 35.4070(b)(3)](/cfr/40/35.4070.md?p=b-3) allows;
- (g) Any activities or expenditures for your group's members' travel;
- (h) Generation of new primary data such as well drilling and testing, including split sampling;
- (i) **Reopening or challenging final EPA decisions such as—**
  - (1) Records of Decision; and/or
  - (2) Disputes with EPA under its dispute resolution procedures set forth [2 CFR](/cfr/2.md) Part1500 [Subpart E](/cfr/40/subpartE.md) (see [§ 35.4245](/cfr/40/35.4245.md)); and
- (j) Generation of new health data through biomedical testing (for example, blood or urine testing), clinical evaluations, health studies, surveillance, registries, and/or public health interventions.

## Notes

### Amendments

[65 FR 58858, Oct. 2, 2000, as amended at 79 FR 76058, Dec. 19, 2014]

### Authority

Authority: 42 U.S.C. 9617(e); sec. 9(g), E.O. 12580, 52 FR 2923, 3 CFR, 1987 Comp., p. 193.

### Source

Source: 65 FR 58858, Oct. 2, 2000, unless otherwise noted.

### Authority

Authority: 42 U.S.C. 7401 et seq.; 33 U.S.C. 1251 et seq.; 42 U.S.C. 300f et seq.; 42 U.S.C. 6901 et seq.; 7 U.S.C. 136 et seq.; 15 U.S.C. 2601 et seq.; 42 U.S.C. 13101 et seq.; Pub. L. 104-134, 110 Stat. 1321, 1321-299 (1996); Pub. L. 105-65, 111 Stat. 1344, 1373 (1997), 2 CFR 200.

### Amendments

[65 FR 58858, Oct. 2, 2000, as amended at 79 FR 76058, Dec. 19, 2014]